#Japan #Tokyo #Toyo Seikan #Deolica #Japan Organ Pharma

Collaborative Breakthrough for Healthcare Odor Control

In a significant advancement, Toyo Seikan Group Holdings and Japan Organ Pharma have come together to develop a new odor-eliminating sheet specifically designed for the medical and nursing sectors. The product, part of the "Deolica" series, aims to address the unpleasant odors associated with medical conditions and caregiving environments, thereby enhancing the quality of care.

Product Overview

The newly developed odor control sheet is categorized as a hygienic item and effectively suppresses odors stemming from cancer wounds, pressure sores, and bodily waste. Designed to wrap over existing dressings and bandages, these roll-type sheets utilize a specialized agent based on porous silica found in the Deolica line. The deodorizing strength of the chemical adsorption ensures safety for skin contact, making it a viable addition to healthcare practices.

Planned for nationwide distribution by 2025 in medical institutions and nursing facilities, this innovative product is set to change the landscape of odor management in healthcare settings.

The Need for Innovation

Persistent odor problems within healthcare and caregiving environments have long posed challenges. Not only do these odors affect the patients directly, but they can also be detrimental to the mental well-being of healthcare providers and surrounding individuals. Recognizing this deep-seated issue, Toyo Seikan Group, known for its rapid and multi-functional deodorizing agents, sought to apply its Deolica technology towards medical environments. This collaborative effort with Japan Organ Pharma has resulted in extensive research, improvements based on insights gathered from practitioners in medical and caregiving fields, and the eventual development of this new product.

The joint effort highlights the importance of combining practical deodorization with user-friendly design, ultimately aiming to mitigate odor issues faced by caregivers and patients alike.

Future Directions

Beyond the roll-type sheets, further applications of Deolica technology are being explored. Both companies are considering the development of aerosol sprays and mist sprays, as well as applications in wound covering materials classified as medical devices, broadening the potential use of their innovative solutions.

About Toyo Seikan Group

Toyo Seikan Group is a leading comprehensive packaging container manufacturer, providing a variety of containers made from metals, plastics, paper, and glass, globally. With a focus on packaging, the company also engages in engineering, filling and logistics, steel-related work, functional materials, and real estate sectors. In pursuit of sustainable practices, Toyo Seikan Group has laid out its long-term vision aimed at maximizing stakeholder value while ensuring environmental responsibility. Founded in 1917, the group comprises 44 domestic companies, including Toyo Seikan Group Holdings, and 50 international affiliates, employing approximately 19,000 staff.

As industries continue to evolve, the collaboration between Toyo Seikan Group and Japan Organ Pharma exemplifies a proactive approach toward improving the lives of those in healthcare settings, ultimately contributing to a more dignified and pleasant experience for patients and caregivers. For more details on the Deolica series, visit Deolica Website.